Parent Project Muscular Dystrophy and Sarepta Therapeutics hosted a webinar on November 24, 2020 for a discussion about the SRP-9001 gene therapy development program. * This webinar recording contains edits to content requested by the company. Research & Clinical Trial Webinars,Webinars 4 years ago You may also like 59:38 Supporting Families Through Decision Making 10 months ago Care Webinars,Webinars palliative care 52:31 Affinity Duchenne™ and Affinity Beyond™: Updates on Investigational RGX-202 from REGENXBIO 10 months ago Research & Clinical Trial Webinars,Webinars 31:23 Advocating for Access: Insurance 101 11 months ago Care Webinars,Webinars 29:12 Advocating for Access: Navigating Approved Therapies in Duchenne 12 months ago Care Webinars,Webinars 1:11:00 Webinar: ELEVIDYS Approval: What this means for you and your family 1 year ago Care Webinars,Webinars 46:01:00 Webinar: ENVISION Study Update with Sarepta Therapeutics 1 year ago Research & Clinical Trial Webinars,Webinars 37:54 Community Town Hall: SRP-9001 Advisory Committee Update (May 2023) 1 year ago Research & Clinical Trial Webinars,Webinars 55:52 Webinar: Edgewise — A Novel Approach Designed to Protect Muscle in Becker (May 2023) 1 year ago Research & Clinical Trial Webinars,Webinars «12345…25»Page 3 of 25
by: Parent Project Muscular Dystrophy
